Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Aventis Pasteur launches Hexavac, a significant advance in childhood vaccination

Jan. 19, 2001

Antex receives SBIR grant to develop microbead vaccine for traveler's diarrhea

Jan. 17, 2001

Human Genome Sciences licenses protein purification technology from Dyax

Jan. 17, 2001

DPP IV inhibitors synthesized at MCRF and their use

Jan. 16, 2001

Corixa's RC-529 adjuvant enters phase III for HBV

Jan. 16, 2001

Triptolide prodrug is highly effective in lethal murine GVHD model

Jan. 12, 2001

Immunosuppressants acting as P2X7 receptor antagonists claimed by AstraZeneca

Jan. 12, 2001

Vasogen begins immune modulation therapy clinical trials in CLL

Jan. 12, 2001

Antex Biologics' Campylobacter vaccine shows promise in phase II

Jan. 11, 2001

ID Biomedical seeks clearance to initiate phase I/II clinical trial of StreptAvax

Jan. 11, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 12, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld Science
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...